Get started
Author

Sarah Heringer

Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2
2021 · Matthias Tenbusch, Sofie Schumacher, et al. · The Lancet Infectious Diseases · 115
PDF
Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2
2022 · Emanuel Vogel, Katharina Kocher, et al. · EBioMedicine · 31
PDF
VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment
2022 · Jon Salmanton-García, Fiona A. Stewart, et al. · Vaccine · 30
A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network
2022 · Julia M. Neuhann, Jannik Stemler, et al. · Trials · 10
PDF
Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1)
2023 · Julia M. Neuhann, Jannik Stemler, et al. · Vaccine · 8
Reason and reality—identifying barriers to patient enrolment for clinical trials in invasive candidiasis
2022 · Rosanne Sprute, Jan H Grothe, et al. · Journal of Antimicrobial Chemotherapy · 5
PDF
The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE Consortium
2023 · Dimitrios Poulimeneas, Markela Koniordou, et al. · Vaccines · 4
PDF
Epidemiology of Acute Respiratory Infection with SARS-CoV-2, Influenza A & B Viruses, Respiratory Syncytial Virus, and Adenovirus in VACCELERATE Volunteers in Germany
2023 · Julia Alexandra Nacov, Jon Salmanton-Garcia, et al. · SSRN Electronic Journal · 3
Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)
2024 · Jannik Stemler, Lusine Yeghiazaryan, et al. · International Journal of Infectious Diseases · 1
PDF
2383. Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: a randomised trial in adults ≥75 years (EU-COVAT-1) from the VACCELERATE consortium
2023 · Jon Salmanton-Garcia, Julia M Neuhann, et al. · Open Forum Infectious Diseases · 1
PDF
Immunogenicity and Reactogenicity of a First Booster with NT162b2or Full-Dose mRNA-1273: A Randomised VACCELERATE Trial in Adults ≥75 Years (EU-COVAT-1)
2023 · Julia Neuhann, Jannik Stemler, et al. · SSRN Electronic Journal · 1
Point prevalence assessments of five respiratory viruses in adults ≥ 50 years of age in Germany by multi-pathogen rapid antigen testing on June 1, 2024, and December 15, 2024
2026 · Miranda Anggitakirana, Julia A. Nacov, et al. · Infection
PDF
Immunogenicity, Reactogenicity and Safety to Assess Booster Vaccinations with BNT162b2 or Full-Dose mRNA-1273 in Adults ≥75 Years (EU-COVAT-1-AGED) – Final Report
2025 · Jannik Stemler, Lusine Yeghiazaryan, et al. · SSRN Electronic Journal
Self-Testing of 5 Respiratory Viruses in Adult VACCELERATE Volunteers in Germany Allowing Large-Scale Epidemiological Studies in Real-Time
2024 · Julia Alexandra Nacov, Jon Salmanton-Garcia, et al. · SSRN Electronic Journal
380. The first two years of the European VACCELERATE volunteer registry
2023 · Jon Salmanton-Garcia, Fiona A Stewart, et al. · Open Forum Infectious Diseases
PDF
P1562: the First Two Years of the European Vaccelerate Volunteer Registry
2023 · Jon Salmanton-García, Fiona A. Stewart, et al. · HemaSphere
Immunogenicity, Reactogenicity and Safety of a Second Booster with BNT162b2 or Full-Dose mRNA-1273: A Randomised VACCELERATE Trial in Adults ≥75 Years (EU-COVAT-1-AGED Part B)
2023 · Jannik Stemler, Lusine Yeghiazaryan, et al. · SSRN Electronic Journal
STUDY PROTOCOL A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): A trial conducted within the VACCELERATE network
2022 · Julia Maria Neuhann, Jannik Stemler, et al. · Research Square
PDF
Works count: 18
Citation count: 209
H-index: 5
I10-index: 4
Year
Topic
Type